Compass Therapeutics Provides Corporate Update
05 janv. 2024 08h00 HE
|
Compass Therapeutics
We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer...
Compass Therapeutics to Participate in Upcoming Investor Events
07 nov. 2023 08h00 HE
|
Compass Therapeutics
BOSTON, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Bespoke Metrics and Procore Deepen Collaboration to Streamline Preconstruction Phase
12 sept. 2023 10h00 HE
|
Bespoke Metrics
TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- COMPASS by Bespoke Metrics, a leading provider of prequalification and risk management technology, today announced the integration of its prequalification...
Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ
26 avr. 2023 08h30 HE
|
Compass Therapeutics
BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
Compass Therapeutics to Participate in the SVB Securities Global Biopharma Conference
02 févr. 2023 08h30 HE
|
Compass Therapeutics
BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...
COMPASS MINERALS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Compass Minerals International, Inc. and Encourages Investors to Contact the Firm
16 déc. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rite Aid, Compass, Polished, and US Bancorp and Encourages Investors to Contact the Firm
12 déc. 2022 23h01 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against International Game, Compass, Polished, and US Bancorp, and Encourages Investors to Contact the Firm
07 déc. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
COMPASS Prequalification Tool launches the 2022 COMPASS Select List
06 déc. 2022 11h07 HE
|
Bespoke Metrics
TORONTO, Dec. 06, 2022 (GLOBE NEWSWIRE) -- COMPASS, by Bespoke Metrics, has released its inaugural COMPASS Select List. This list recognizes the top subcontractors in the COMPASS Prequalification...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, and Rite Aid, Compass, and Polished and Encourages Investors to Contact the Firm
02 déc. 2022 20h50 HE
|
Bragar Eagel & Squire
NEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...